Sinomenine Suppresses Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting O‐ GlcNAcylation of SP1
Clinical and Experimental Pharmacology and Physiology · 2025
DOI: 10.1111/1440-1681.70057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2025. Verfasst von Lanqin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cell Movement, Morphinans. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Zhejiang Province Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Sinomenine (SIN) is an extract obtained from the plant Sinomenium acutum , which has been reported in hepatocellular carcinoma (HCC) and many other different types of human cancers as an anti‐tumour agent. However, the molecular mechanism modulated or altered by SIN in HCC progression remains to be investigated. This study aims to uncover the molecular mechanism contributing to the tumour‐suppressing effect of SIN in HCC. At first, HCC cells were treated with SIN for functional detections. Results of functional assays demonstrated that SIN was an efficient inhibitor of HCC cell viability, migration, and invasion. Next, O‐GlcNAcylation and its removal OGA were found to be regulated by SIN treatment in HCC cells. According to rescue functional assays, OGA knockdown strengthened HCC cell viability, migration, and invasion suppressed by SIN. Moreover, as detected by mechanism experiments, OGA directly interacted with SP1 and blocked SP1 O‐GlcNAcylation at site T407, indicating that SP1 was downregulated by OGA‐mediated deglycosylation. Additionally, silencing of SP1 recovered the suppressing effects of SIN on HCC cell proliferation, migration, and invasion attenuated by OGA knockdown. Finally, SIN treatment inhibited the tumour tissue growth in vivo. In summary, this study unmasked the anti‐tumour effect of SIN in HCC and SIN exerted functions by regulating OGA‐mediated downregulation of SP1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
- General Surgery, The First People's Hospital of Jiande, Zhejiang, China.
Förderung
- Zhejiang Province Administration of Traditional Chinese Medicine
Zitieren
APA
Liu, L., Peng, J., Chen, H., Chen, J., Xu, W., & Han, Y. (2025). Sinomenine Suppresses Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting O‐ GlcNAcylation of SP1. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70057
Vancouver
Liu L, Peng J, Chen H, Chen J, Xu W, Han Y. Sinomenine Suppresses Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting O‐ GlcNAcylation of SP1. Clinical and Experimental Pharmacology and Physiology. 2025. doi:10.1111/1440-1681.70057
BibTeX
@article{Liu2025,
author = {Liu, Lanqin and Peng, Junwen and Chen, Haixia and Chen, Jie and Xu, Wei and Han, Yehong},
title = {Sinomenine Suppresses Hepatocellular Carcinoma Cell Migration and Invasion by Inhibiting O‐ GlcNAcylation of SP1},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2025},
doi = {10.1111/1440-1681.70057}
}
EUVIMED